OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
October 21, 2022
Experts in dermatology review how JAK inhibitors will impact dermatology care across the board.
Jerry Bagel, MD, MS, and Brett King, MD, PhD, consider how new advances in oral medication will impact physicians’ and patients’ decision-making when it comes to treatment of alopecia areata, vitiligo, and atopic dermatitis.
October 14, 2022
Dermatology experts discuss clinical specifics of JAK [Janus kinase] inhibitors and their impact on the treatment of patients with vitiligo and alopecia areata.
October 07, 2022
Jerry Bagel, MD, MS, and Brett King, MD, PhD, discuss the use of topical JAK inhibitors in alopecia areata, vitiligo, and atopic dermatitis.